Sharon Barber-Lui Buys 29,868 Shares of PureTech Health (LON:PRTC) Stock

PureTech Health plc (LON:PRTC) insider Sharon Barber-Lui purchased 29,868 shares of PureTech Health stock in a transaction dated Tuesday, July 7th. The stock was bought at an average cost of GBX 119 per share, with a total value of £35,542.92.

PureTech Health Stock Up 1.6%

Shares of PureTech Health stock opened at GBX 120 on Thursday. The firm’s 50 day moving average price is GBX 129.88 and its 200-day moving average price is GBX 127.13. The company has a quick ratio of 2.51, a current ratio of 6.59 and a debt-to-equity ratio of 6.33. PureTech Health plc has a 52-week low of GBX 104.71 and a 52-week high of GBX 148. The company has a market cap of £292.10 million, a P/E ratio of -2.61 and a beta of 0.79.

About PureTech Health

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia.